TrialNeurology(R) neuroimmunology & neuroinflammation2020

Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS.

Hans-Peter Hartung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.